Zhejiang Jingxin Pharmaceutical Co Ltd
Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemi… Read more
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.040x
Based on the latest financial reports, Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a cash flow conversion efficiency ratio of 0.040x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥227.64 Million) by net assets (CN¥5.69 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Jingxin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Zhejiang Jingxin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Jingxin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Jingxin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Maze Therapeutics, Inc. Common Stock
NASDAQ:MAZE
|
-0.065x |
|
New World Development Company Limited
PINK:NWWDF
|
0.036x |
|
Bringspring Science and Tech
SHE:300290
|
0.015x |
|
Insperity Inc
NYSE:NSP
|
-6.043x |
|
BNP Paribas Bank Polska S.A.
WAR:BNP
|
-0.032x |
|
Lifestyle Communities Limited
PINK:LCOMF
|
0.028x |
|
Community Trust Bancorp Inc
NASDAQ:CTBI
|
0.017x |
|
Green Plains Renewable Energy Inc
NASDAQ:GPRE
|
0.087x |
Annual Cash Flow Conversion Efficiency for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Jingxin Pharmaceutical Co Ltd from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥6.00 Billion | CN¥726.16 Million | 0.121x | -18.72% |
| 2023-12-31 | CN¥5.54 Billion | CN¥824.69 Million | 0.149x | -10.04% |
| 2022-12-31 | CN¥5.17 Billion | CN¥855.78 Million | 0.165x | +119.29% |
| 2021-12-31 | CN¥4.84 Billion | CN¥365.02 Million | 0.075x | -42.18% |
| 2020-12-31 | CN¥3.93 Billion | CN¥513.21 Million | 0.130x | -9.54% |
| 2019-12-31 | CN¥3.71 Billion | CN¥535.30 Million | 0.144x | -1.51% |
| 2018-12-31 | CN¥3.57 Billion | CN¥523.40 Million | 0.146x | +50.87% |
| 2017-12-31 | CN¥3.97 Billion | CN¥385.01 Million | 0.097x | -6.78% |
| 2016-12-31 | CN¥2.43 Billion | CN¥252.69 Million | 0.104x | +62.70% |
| 2015-12-31 | CN¥2.26 Billion | CN¥144.69 Million | 0.064x | -57.47% |
| 2014-12-31 | CN¥1.40 Billion | CN¥210.49 Million | 0.151x | +10.88% |
| 2013-12-31 | CN¥817.98 Million | CN¥111.03 Million | 0.136x | +73.98% |
| 2012-12-31 | CN¥772.58 Million | CN¥60.28 Million | 0.078x | -13.88% |
| 2011-12-31 | CN¥766.17 Million | CN¥69.41 Million | 0.091x | -51.30% |
| 2010-12-31 | CN¥320.13 Million | CN¥59.55 Million | 0.186x | -57.79% |
| 2009-12-31 | CN¥307.17 Million | CN¥135.38 Million | 0.441x | +345.67% |
| 2008-12-31 | CN¥303.19 Million | CN¥29.98 Million | 0.099x | +133.82% |
| 2007-12-31 | CN¥299.61 Million | CN¥-87.60 Million | -0.292x | -5856.81% |
| 2006-12-31 | CN¥294.62 Million | CN¥-1.45 Million | -0.005x | -102.30% |
| 2005-12-31 | CN¥289.64 Million | CN¥61.82 Million | 0.213x | +842.74% |
| 2004-12-31 | CN¥284.03 Million | CN¥6.43 Million | 0.023x | -95.66% |
| 2003-12-31 | CN¥88.44 Million | CN¥46.18 Million | 0.522x | -27.68% |
| 2002-12-31 | CN¥63.02 Million | CN¥45.50 Million | 0.722x | -- |